Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02969460 · ClinicalTrials.gov registry record · NA
Neurotrack Virtual Cognitive Health Study
A NA study, sponsored by Evidation Health.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT02969460: Completed NA study, sponsored by Evidation Health.
NCT02969460 is a NA study that has completed, run by Evidation Health. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02969460, a NA study, has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The Neurotrack Virtual Cognitive Health Study is a 12-month long, prospective study that aims to evaluate the impact of the Neurotrack Virtual Cognitive Health Coaching Program on cognitive ability, anxiety and depression, and lifestyle behaviors for individuals who show signs of subjective cognitive decline.
Primary Outcome
Repeatable Battery for the Assessment of Neuropsychological Status total score
Interventions
- BEHAVIORAL Neurotrack Virtual Cognitive Health Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2016-11-30 |
| Est. Completion | 2018-04-18 |
| Phase | NA |
What the finished NCT02969460 record still lists
NCT02969460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Neurotrack Virtual Cognitive Health Program is the first listed.
NCT02969460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02969460 about?
NCT02969460 is a clinical study titled "Neurotrack Virtual Cognitive Health Study". The Neurotrack Virtual Cognitive Health Study is a 12-month long, prospective study that aims to evaluate the impact of the Neurotrack Virtual Cognitive Health Coaching Program on cognitive ability, anxiety and depression, and lifestyle behaviors for individuals who show signs of subjective cognitiv...
What is the current status of trial NCT02969460?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2016-11-30. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT02969460?
The interventions under investigation include: Neurotrack Virtual Cognitive Health Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02969460?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02969460's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI